Consideration of mycophenolate mofetil for idiopathic pulmonary fibrosis

• Published in: Medical hypotheses Vol. 57; no. 6; pp. 701 - 702
• Main Author: Altschuler, E.L.
• Format: Journal Article
• Language: English
• Published: Kidlington Elsevier Ltd 01.12.2001; Elsevier
• Subjects: Biological and medical sciences; Humans; Immunosuppressive Agents - therapeutic use; Lung Transplantation; Medical sciences; Mycophenolic Acid - analogs & derivatives; Mycophenolic Acid - therapeutic use; Pharmacology. Drug treatments; Pulmonary Fibrosis - drug therapy; Pulmonary Fibrosis - etiology; Pulmonary Fibrosis - surgery; Respiratory system; Mofetil; Cell proliferation; Lung disease; Mycophenolic acid; Respiratory disease; Leukocyte; Treatment efficiency; Lung; Idiopathic; Bronchopulmonary; Chemotherapy; Depletion; Treatment; Fibrosis; Bronchus disease; Inhibition; Mechanism of action; Discussion; Fibroblast

Idiopathic pulmonary fibrosis (IPF) is an inflammatory disorder of the lungs of unknown etiology, with no effective treatment. Besides the recent finding of utility of mycophenolate mofetil (MMF) in a case of refractory interstitial lung disease associated with ulcerative colitis, I suggest that the...